Skip to main content
. Author manuscript; available in PMC: 2025 Mar 1.
Published in final edited form as: J Surg Oncol. 2023 Nov 20;129(3):481–488. doi: 10.1002/jso.27521

Table 4.

Association between neoadjuvant treatment strategies with overall survival on adjusted cox proportional hazards regression.

Unmatched Matched
Hazard Ratio (95% Confidence Interval)

Neoadjuvant Treatment a
  Chemotherapy 1.00 (REF) 1.00 (REF)
  Chemoradiation 1.07 (1.01-1.13) 1.10 (1.03-1.18)
a

Adjusting for gender, age, race, insurance status, facility type, Charlson/Deyo score, tumor location, tumor differentiation, lymphovascular invasion, tumor size, clinical T-category, and clinical N-category.